Drug Type Small molecule drug |
Synonyms D 264, D264 |
Target |
Mechanism D3 receptor agonists(Dopamine D3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H37N5S |
InChIKeyYDLWLYDTYNHXBM-UHFFFAOYSA-N |
CAS Registry2650449-36-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | US | 12 Apr 2008 |